Skip to main content
Premium Trial:

Request an Annual Quote

Discovery Life Sciences Acquires QualTek Molecular Laboratories

NEW YORK – Discovery Life Sciences announced today that it has acquired immunohistochemistry services provider QualTek Molecular Laboratories. 

The deal will significantly increase the range of Discovery's existing histopathology services and will help the company develop innovative flow cytometry and cell-based laboratory services, it said. The merger will also complement Discovery's HudsonAlpha Discovery sequencing and bioinformatics laboratory, one of the world's largest commercial biorepositories and biospecimen procurement networks, the company added.

Financial terms of the deal were not disclosed.

"We founded QualTek 22 years ago and have successfully realized our vision of using IHC as a platform for personalized medicine to help increase cancer patient response to therapy," QualTek Chief Operating Officer Frank Lynch said in a statement. "We can now leverage direct access to the largest bank of annotated FFPE blocks to allow our biopharma partners to design clinical trials strategically, based on understanding the expression of their target proteins in specific patient populations."  

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.